Sagent Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT PHARMS, and what generic and branded alternatives to SAGENT PHARMS drugs are available?
SAGENT PHARMS has seventy-eight approved drugs.
There is one tentative approval on SAGENT PHARMS drugs.
Summary for Sagent Pharms
| US Patents: | 0 |
| Tradenames: | 62 |
| Ingredients: | 60 |
| NDAs: | 78 |
Drugs and US Patents for Sagent Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 091684-001 | Oct 31, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sagent Pharms Inc | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 209967-002 | Jan 16, 2020 | AP1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sagent Pharms Inc | LINEZOLID | linezolid | SOLUTION;INTRAVENOUS | 204696-002 | Mar 2, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
